SBH
NUTX

Segall Bryant & Hamill’s Nutex Health NUTX Stock Holding History

Segall Bryant & Hamill’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,499
Closed -$2.14M – 644
2026
Q1 		$2.14M Sell
22,499
-399
-2% -$48.9K 0.03% 416
2025
Q4 		$3.77M Sell
22,898
-276
-1% -$36.6K 0.05% 347
2025
Q3 		$2.39M Buy
+23,174
New +$2.27M 0.03% 405

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Segall Bryant & Hamill's NUTX Position: Q2 2026 in Review

Segall Bryant & Hamill sold out of Nutex Health (NUTX) in Q2 2026, closing a stake of 22,499 shares — an estimated $2.14M sold.

Segall Bryant & Hamill first reported a position in NUTX in Q3 2025 and held it in 3 quarters. The position peaked at $3.77M in Q4 2025. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Segall Bryant & Hamill reported no remaining Nutex Health position as of Q2 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 22,499 Nutex Health shares in Q2 2026, an estimated $2.14M.
  • Segall Bryant & Hamill first reported a position in Nutex Health in Q3 2025 and held it in 3 quarters.
  • Segall Bryant & Hamill's Nutex Health position peaked at $3.77M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.